Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Treasury Shares (2018 - 2024)

Historic Treasury Shares for Protagonist Therapeutics (PTGX) over the last 7 years, with Q4 2024 value amounting to $844708.0.

  • Protagonist Therapeutics' Treasury Shares rose 2712.11% to $844708.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $844708.0, marking a year-over-year increase of 2712.11%. This contributed to the annual value of $844708.0 for FY2024, which is 2712.11% up from last year.
  • Per Protagonist Therapeutics' latest filing, its Treasury Shares stood at $844708.0 for Q4 2024, which was up 2712.11% from $664491.0 recorded in Q4 2023.
  • Protagonist Therapeutics' Treasury Shares' 5-year high stood at $864112.0 during Q1 2023, with a 5-year trough of $262608.0 in Q2 2020.
  • Its 5-year average for Treasury Shares is $548524.5, with a median of $527595.0 in 2021.
  • In the last 5 years, Protagonist Therapeutics' Treasury Shares crashed by 3389.62% in 2020 and then skyrocketed by 8089.32% in 2022.
  • Quarter analysis of 5 years shows Protagonist Therapeutics' Treasury Shares stood at $262608.0 in 2020, then skyrocketed by 54.59% to $405972.0 in 2021, then soared by 71.05% to $694414.0 in 2022, then decreased by 4.31% to $664491.0 in 2023, then grew by 27.12% to $844708.0 in 2024.
  • Its Treasury Shares was $844708.0 in Q4 2024, compared to $664491.0 in Q4 2023 and $736989.0 in Q2 2023.